Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > Mackie Research
View:
Post by fdfd12 on Dec 03, 2015 10:23am

Mackie Research

cuts to hold
Comment by sunshine7 on Dec 03, 2015 10:25am
any details or analysis of this report?
Comment by USNOOZEULOOZE on Dec 03, 2015 10:32am
This post has been removed in accordance with Community Policy
Comment by pineapple1 on Dec 03, 2015 10:26am
This post has been removed in accordance with Community Policy
Comment by sunshine7 on Dec 03, 2015 11:40am
I suppose we will get an update to 2016 forecasts in the coming month as CXR gets a chance to read the books and identify unrealized opportunities. IMO earlier forecasts were likely conservative with the unintended consequence of lower target prices (still higher than today's price). Expect surprise to the upside and the analysts like Mackie to revise their recommendations.
Comment by cg16 on Dec 03, 2015 11:46am
who cares what Mackie Research think they know? Mark Thompson is personally buying shares...
Comment by Tobuyornot on Dec 03, 2015 10:30am
Certainly seems influential!  Anybody able to put some flesh on that report?
Comment by sunshine7 on Dec 03, 2015 10:41am
In an analyst report shared with investors by Mackie Research on Wednesday morning (Sept 9 2015), Concordia Healthcare Corp (NASDAQ:CXRX) had its target price upped to $81.00. The firm presently has Hold rating on the stock... not very good are they? Now they are a larger, more diversified company and the target is lower? Would like to see their latest report.
Comment by sunshine7 on Dec 03, 2015 10:53am
On Oct 26 2015 Mackie had a target of $42.50USD and spec buy rating. Adjusted earnings are expected between US$6.29 and US$6.77, the Oakville, Ontario-based company said in a statement on Monday. [that is SP ~6.5x EPS] That fell short of the $6.88 per share.average estimate of 4 analysts polled by Capital IQ. [expect CXR to beat their conservative forecast] Revenue is anticipated to be between $1 ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities